Nomir is developing a pipeline of therapeutic device-based products. Nomir’s core technology, Noveon®, harnesses the power of optical energy.
Clinically Validated Results
Nomir has two clearance by 510(K) Notification from the U.S. Food and Drug Administration (FDA) to utilize the company’s Noveon device during contact and non-contact surgical procedures of the skin, subcutaneous tissues and nasal passages in dermatology, plastic surgery, podiatry, and otolaryngology.
Nomir has a broad patent portfolio on systems, methods and unique photo-biological mechanism claims. Nomir’s comprehensive intellectual property portfolio is comprised of issued patents protecting the core technology platform, mechanism of action, as well as several active filings to further broaden its patent estate and deliver on the company’s IP strategy.
top of page